Will Strong HIV Sales Drive Gilead's (GILD) Q3 Earnings?

Biotech major Gilead Sciences Inc. GILD is slated to report third-quarter 2019 results on Oct 24, after market close.

Gilead has a pretty decent track record, with earnings beating estimates in three of the last four quarters, the average being 2.20%. In the last reported quarter, the company’s earnings beat expectations by 4.60%.